RE: Sp15 Oct 2023 20:52
Steph, 2022 was a grim year for investors with the effect of inflation from QT made worse by a war, political upheaval in UK and rising interest rates coupled with the potential for food rationing. The world was beginning to recover post Covid-19 with supply chains disrupted and insufficient people to fill the skilled vacancies for any expansion of business.
I have to be honest in WANTING the share price to remain depressed for another couple of months at least. It gives me time to structure my portfolio to be able to strengthen tomorrows winners and release those that are shining at the moment.
FWIW, the future (as far as my limited vision determines) has growth from businesses involved in mining, pharmaceuticals, IT, AI, leisure and medicine. Yes there will be a few gems in other sectors as the transition away from reliance on fossil fuels will reveal, but without the raw material for energy, World population will continue to grow to ensure that medicines and new medicines will be needed the world will become better connected through commputerisation, Machine Learning (ML) through AI MIGHT do the drudgery work to allow richer people to have more time in leisure activity, but not forgetting that as we age, so medicines to cope with age needs to evolve.
I have to admit, that most of my picks over the last 40 or so years in the theme of medical advance that are in pre-clinical, clinical and Stage 1, have failed and I have taken losses on the nose of around £90,000 from investing directly in listed companies. Having only discovered Investment Trusts in the last 12 years, my appetite for "themed" investment is growing.
The more observant will note I have cancelled my "premium" status. I wanted live prices but these have been so shockingly poor in this site with wild inaccuracies, coupled with an eye watering increase in fee, that my justification to have accurate portfolio valuation can be a day or two out and does not need to be micromanaged.